Injection site eosinophilic granulomas and collagenolysis in 3 horses.

Three horses were presented with a history of having developed raised cutaneous nodules, within 24-48 hours, in areas of previous injections using standard silicone-coated hypodermic needles. Skin biopsies were taken from a selected cutaneous nodule from all horses for histopathologic evaluation. Histologically, the nodules were consistent with a diagnosis of equine eosinophilic granuloma. A hypersensitivity reaction to the silicone, or another component of the coating formulation, was hypothesized to be responsible for these lesions. Two horses were experimentally injected using both coated and noncoated stainless steel hypodermic needles and skin biopsies were obtained 14 days after injection. The sites of the coated needle injections were characterized by severe eosinophilic granulomatous inflammation with and without collagenolysis. The eosinophilic granulomas with and without collagenolysis observed in these horses are proposed to represent a complex immunologic response to the silicone-based coating of most hypodermic needles.

Use of etretinate for treatment of primary keratinization disorders (idiopathic seborrhea) in cocker spaniels, west highland white terriers, and basset hounds.

An open clinical trial was used to evaluate the synthetic retinoid, etretinate, for treatment of idiopathic seborrhea in Cocker Spaniels, West Highland White Terriers, and Basset Hounds. Clinical and histologic improvement was seen in the Cocker Spaniels. Etretinate had no beneficial effect on the skin disease of the West Highland White Terriers or the Basset Hounds. Etretinate treatment did not alter the type or degree of otitis externa. Clinical side effects were minimal. Relevant laboratory abnormalities were not detected.

Clinical evaluation of etretinate for the treatment of canine solar-induced squamous cell carcinoma and preneoplastic lesions.

BACKGROUND: Tumors of the skin and subcutaneous tissue account for 30% of all canine neoplasms. Canine solar-induced squamous cell carcinoma (SCC) is the most frequently reported canine cutaneous neoplasm. OBJECTIVE: The purpose of this study was to provide preliminary observations on the safety and efficacy of etretinate for the treatment of solar-induced SCC and associated preneoplastic lesions in dogs. METHODS: Etretinate was administered to 10 dogs at 1 mg/kg twice daily for a minimum of 90 days. RESULTS: Clinically, two dogs showed complete resolution of their preneoplastic lesions, three dogs had partial responses, two dogs maintained stable disease, and three dogs showed progression of lesions after 90 days of etretinate administration. Three dogs showed histologic improvement, four dogs showed no changes, and three dogs showed evidence of progressing SCC. Treatment-related biochemical abnormalities included reversible hypertriglyceridemia and transient serum liver enzyme elevations in three dogs. CONCLUSION: These preliminary findings suggest that etretinate, at the dosage administered, may provide therapeutic efficacy for solar-induced preneoplastic lesions in the dog, particularly for those multifocal lesions not easily managed by local methods of therapy.

A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas.

The relationship between skin pigmentation and piliation and the development of hemangiomas and hemangiosarcomas in the dermis and subcutaneous tissue was studied in 212 dogs. These 212 dogs had a combined total of 306 tumors; 38 of these 212 dogs had two or more of the same tumor in a different location or a combination of hemangioma and hemangiosarcoma. The average age of the dogs at the time of excision of these tumors was greater than 10 years. There was no sex predilection for the presence or absence of tumors. Cutaneous hemangiomas (73%) were more common than cutaneous hemangiosarcomas (27%). Hemangiomas had no predilection for dermis (51%) or subcutaneous tissue (47%), but hemangiosarcomas had a marked predilection for dermis (73%) over subcutaneous tissue (7%). Dogs with short hair coats and lightly pigmented skin had more hemangiomas and hemangiosarcomas of the dermis (65%) than did dogs with variable length hair coats and pigmentation (28%). Dogs with short hair coats and lightly pigmented skin had fewer hemangiomas and hemangiosarcomas of the subcutaneous tissue (10%) than did dogs with variable length hair coats and pigmentation (22%). Dogs with short hair coats and lightly pigmented skin also had more hemangiomas and hemangiosarcomas of ventral glabrous skin (65%) than did dogs with variable length hair coats and pigmentation (22%). In addition, there was no predilection of subcutaneous hemangiosarcoma for haired (33%) versus glabrous (33%) skin, but dermal hemangiosarcoma had a marked predilection for the glabrous skin (63%) when compared with haired skin (10%). The increased incidence of dermal hemangiomas and hemangiosarcomas in ventral glabrous skin suggests an association between solar radiation and the biologic properties of glabrous skin in the genesis of these tumors.

Cutaneous fungal flora in twenty horses free of skin or ocular disease.

The fungal flora of the hair and underlying skin from 2 sites was examined qualitatively in 20 horses free of skin or ocular disease. Fungi were isolated from both the hair and the underlying skin of all 20 horses. Twenty-two genera regarded commonly as saprophytes were identified and an additional 2 fungi resembled the perfect state of the cutaneous pathogenic genera Microsporum and Trichophyton. Cladosporium spp, Penicillium spp, and Rhizopus spp were the most frequently isolated saprophytes. In general, similar fungi were isolated from the hair and underlying skin, and differences were not noted in isolates from the saddle and rump regions.

Epidermal cell renewal in the horse.

Epidermal cell labeling index and cell renewal time were estimated in 8 adult horses, using autoradiography after [3H]thymidine was given intradermally. The mean labeling index was 1.45 +/- 0.47%, and the mean cell renewal time of the viable epidermis was approximately 17 days.

Dermatosis associated with feeding generic dog food: 13 cases (1981-1982).

The records of 13 dogs with a crusting dermatosis of the mucocutaneous junctions, pressure points, and trunk were evaluated. All of the dogs had been fed corn- and wheat-based commercial dry dog foods that failed to meet the National Research Council's recommendations for balanced nutrition. The dermatosis in all 13 dogs resolved completely after the diet was changed to one that met the National Research Council's recommendations. The disease was similar to that which has previously been called canine dry pyoderma, but is now known to be a zinc-responsive dermatosis.

Circulating immune complex concentrations in selected cases of skin disease in dogs.

Serum samples from 25 clinically normal dogs and 137 base-line serum samples from dogs with skin disease were assayed blindly for presence of circulating immune complexes (CIC). The method used was a solid-phase C1q-binding enzyme-linked immunosorbent assay. This assay detected only IgG-containing CIC that were capable of binding C1q. Statistical analysis revealed that dogs with systemic lupus erythematosus, discoid lupus erythematosus, generalized demodicosis, and recurrent staphylococcal pyoderma had significantly higher mean CIC concentrations than did normal dogs. Dogs with other skin diseases had mean CIC concentrations indistinguishable from those of normal dogs. Presence of CIC in dogs with these dermatopathies may have pathogenetic significance or may be the result of the disease process. Further studies are necessary to define the antigens contained in the immune complexes and the importance of CIC in skin disease of dogs.

Histopathologic features of pyotraumatic dermatitis.

The skin of 17 dogs with pyotraumatic dermatitis was studied microscopically. Two patterns were seen. The first pattern was a superficial, ulcerative, inflammatory process of undetermined cause and pathogenesis. Current recommended treatment, which includes corticosteroids, was believed to be appropriate for such lesions. The second pattern, suppurative folliculitis, was considered to be localized pyoderma. Dogs with severe folliculitis were believed to represent those cases of pyotraumatic dermatitis in which the response to corticosteroid treatment has been poor. It was concluded that antibiotics should be used for treating pyotraumatic dermatitis with suppurative folliculitis, in lesions responding poorly to treatment with corticosteroids, or possibly in any severe lesion of pyotraumatic dermatitis, especially in Golden Retrievers and Saint Bernards.

Actinomycotic mycetoma in a cat.

Actinomycotic mycetoma, a chronic, progressive infection of the subcutaneous tissue characterized by tumefaction, draining sinuses, and grains, was diagnosed in the right hindlimb of a young adult, male cat. The organisms that cause actinomycetoma are soil or plant saprophytes that gain entrance to the skin through abrasion or traumatic implantation. Streptomyces griseus, an organism generally considered to be a saprophyte, was cultured bacteriologically. Despite extensive surgery and long-term antibiotic therapy, the infection persisted, and the cat was euthanatized.

A trial of 13-cis-retinoic acid for treatment of squamous cell carcinoma and preneoplastic lesions of the head in cats.

Ten cats with a total of 15 cancerous or precancerous lesions were examined for clinical response to and histopathologic changes after treatment with 13-cis-retinoic acid. Before treatment was started, the lesions were graded according to clinical severity and biopsied for histopathologic examination. Serum samples were prepared for determining vitamin A concentrations. For comparison, serum vitamin A concentrations in 10 clinically healthy cats were determined. 13-cis-Retinoic acid (approx 3.0 mg/kg) was given to affected cats once a day for an average of 68 days. At the completion of the therapeutic trial, additional biopsy tissues were obtained for histopathologic examination, and serum was assayed for 13-cis-retinoic acid. Of the 15 lesions examined, only 1 showed partial clinical and microscopic improvement during the therapy period. The mean serum vitamin A concentration of the affected cats was not statistically different from that of the 10 healthy cats. The results of this trial indicated that 13-cis-retinoic acid used at this dosage, daily frequency, and duration did not have therapeutic efficacy for squamous cell carcinomas or preneoplastic lesions in the cat and that the mean serum vitamin A concentration did not differ between the affected cats and clinically healthy cats.

The longevity of immunoglobulin preservation in canine skin utilizing Michel's fixative.

Skin biopsy specimens from 7 dogs with immune-mediated skin diseases diagnosed by routine histology and 5 dogs with other skin diseases were placed in Michel's transport medium for 4 to 9 years. Direct immunofluorescence yielded positive results in tissue samples from 3 dogs with pemphigus foliaceus and 2 dogs with discoid lupus erythematosus. Direct immunofluorescence was not seen in tissue samples from 1 dog with pemphigus foliaceus and 5 dogs with non immune-mediated skin diseases. Direct immunofluorescence was seen in skin biopsy specimens maintained in Michel's medium for 4 to 8 years.

Urinary tract infection associated with long-term corticosteroid administration in dogs with chronic skin diseases.

Urinary tract infections were documented in 28 (39%) of 71 dogs receiving long-term corticosteroid therapy for chronic skin diseases. There were no significant differences regarding alternate-day versus daily corticosteroid administration, corticosteroid dosage, or duration of therapy when data for the infected and noninfected groups were compared. A significantly (P less than 0.01 and P less than 0.005, respectively) greater frequency of bacteriuria was seen in female dogs and castrated male dogs receiving corticosteroid therapy. Urine sediment analysis alone was not an adequate means of detecting urinary tract infections in these dogs.

Pemphigus foliaceus of the footpads in three dogs.

Severe hyperkeratinization and villous hypertrophy of the footpads were seen in 3 middle-aged dogs. Peeling, fissuring, swelling, and ulcerations were noted on the margins of severely affected pads. Pain was evident in palpation and ambulation. Lesions were compatible with the traditional diagnosis of "hard pad disease". Histopathologic findings were diagnostic for canine pemphigus foliaceus in all 3 dogs, and direct immunofluorescence in an intercellular pattern was seen in both dogs that were tested. All 3 dogs responded to immunosuppressive dosages of corticosteroids.

Pemphigus foliaceus in dogs: a review of 37 cases.

Thirty-seven dogs with pemphigus foliaceus were seen over a span of 9 years in a veterinary medical teaching hospital. Four breeds of dogs (Bearded Collie, Akita, Newfoundland, Schipperke) were at significant elevated risk when compared with both the dermatology canine case population and the hospital canine population. The mean age of onset was 4.2 years. The dorsal part of the muzzle was the most common site of initial involvement in over 50% of the dogs, and lesions of the head were seen first in 81% of the dogs. Disease progression was gradual (greater than 3 months) in 73% of the dogs. Somewhat bilaterally symmetric scaling, crusting, and alopecia were seen in all of the dogs. Vesicles, pustules, and bullae were not seen commonly, but target lesions with peripheral collarettes were seen frequently. Most dogs had characteristic footpad lesions, with erythematous swelling at the pad margins, cracking, and villous hypertrophy. Generalized exfoliative dermatitis was seen in dogs with widespread disease. Pruritus was noted in less than one half of the dogs. Typical histopathologic findings included subcorneal and intragranular cell layer epidermal pustules, or intrafollicular pustules with prominent acantholysis. Direct immunofluorescence in an intercellular pattern was noted in 76% of the dogs tested and indirect immunofluorescence was noted in 75% of a much smaller sample. Thirty-nine percent of the dogs responded to corticosteroid therapy alone, and 50% and 55% responded, respectively, to prednisone and cytotoxic drugs, and to prednisone with aurothioglucose. Aurothioglucose was successful alone in 27% of the dogs. One-year survival was achieved in 53% of the dogs.